Difficulty: Medium
Average Score: 71%
Practice
The BEST treatment for a 16-year-old female adolescent with Behcet disease involving oral and genital ulcers and erythema nodosum is
Correct answer
A
Rationale
In treating a 16-year-old female adolescent with Behcet disease involving oral and genital ulcers and erythema nodosum, the BEST treatment is colchicine (Option A).
Colchicine is effective in managing the symptoms of Behcet disease by reducing inflammation and preventing flare-ups. It is particularly useful in treating oral and genital ulcers, which are common manifestations of the disease in adolescents.
Azathioprine (Option B) and cyclophosphamide (Option C) are immunosuppressants that are usually reserved for more severe cases of Behcet disease or when colchicine is not effective. These medications have more significant side effects and risks compared to colchicine, making them less suitable as the first-line treatment for this adolescent.
Steroids (Option D) are not the preferred choice for long-term management of Behcet disease due to their side effects, especially in growing adolescents. While steroids may be used for acute flare-ups, they are not recommended as a primary treatment option in this case.
Educationally, understanding the rationale behind choosing colchicine for this adolescent with Behcet disease is crucial for nursing students. It highlights the importance of selecting appropriate treatments based on the patient's age, disease severity, and potential side effects. This knowledge empowers nurses to provide safe and effective care to pediatric patients with complex conditions like Behcet disease.
Colchicine is effective in managing the symptoms of Behcet disease by reducing inflammation and preventing flare-ups. It is particularly useful in treating oral and genital ulcers, which are common manifestations of the disease in adolescents.
Azathioprine (Option B) and cyclophosphamide (Option C) are immunosuppressants that are usually reserved for more severe cases of Behcet disease or when colchicine is not effective. These medications have more significant side effects and risks compared to colchicine, making them less suitable as the first-line treatment for this adolescent.
Steroids (Option D) are not the preferred choice for long-term management of Behcet disease due to their side effects, especially in growing adolescents. While steroids may be used for acute flare-ups, they are not recommended as a primary treatment option in this case.
Educationally, understanding the rationale behind choosing colchicine for this adolescent with Behcet disease is crucial for nursing students. It highlights the importance of selecting appropriate treatments based on the patient's age, disease severity, and potential side effects. This knowledge empowers nurses to provide safe and effective care to pediatric patients with complex conditions like Behcet disease.